Prevalence of Y chromosome microdeletions in infertile Tunisian men. 2014

Wajih Hammami, and Olfa Kilani, and Mariem Ben Khelifa, and Wiem Ayed, and Sonia Abdelhak, and Abderrezzak Bouzouita, and Fethi Zhioua, and Ahlem Amouri
Department of histology and cytogenetics, Institut Pasteur de Tunis, Tunisia, University of Tunis El Manar, LR11IPT05 Laboratory of biomedical genomics and oncogenetics, Institut Pasteur de Tunis, Tunisia.

Yq microdeletions are the leading genetic cause of male infertility and its detection in clinically relevant for appropriate genetic counseling. The objective of this study was to determine the frequency of Y microdeletion in a group of Tunisian infertile men and to compare the prevalence of these abnormalities with other countries and other Tunisian reported series. Totally, 105 Tunisian idiopathic infertile men (74 azoospermic and 31 severe oligozoospermic) were screened for the presence of Y chromosome microdeletions. The screening of Yq microdeletions was performed by two multiplex PCRs using six STS markers recommended by the EAA/EMQN. No microdeletions were detected in the men with severe oligozoospermia. In the azoospermic group, 2/74 (2.7%) patients showed Y chromosome microdeletions. Both had complete deletion of the AZFc region. No microdeletion was identified in the AZFa region or in the AZFb region. The estimated frequency of Y chromosome microdeletions in the present survey was similar to some other reports but lower than that of previous reports in Tunisian populations.

UI MeSH Term Description Entries
D007248 Infertility, Male The inability of the male to effect FERTILIZATION of an OVUM after a specified period of unprotected intercourse. Male sterility is permanent infertility. Sterility, Male,Sub-Fertility, Male,Subfertility, Male,Male Infertility,Male Sterility,Male Sub-Fertility,Male Subfertility,Sub Fertility, Male
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009845 Oligospermia A condition of suboptimal concentration of SPERMATOZOA in the ejaculated SEMEN to ensure successful FERTILIZATION of an OVUM. In humans, oligospermia is defined as a sperm count below 20 million per milliliter semen. Cryptospermia,Cryptozoospermia,Low Sperm Count,Hypospermatogenesis,Oligoasthenoteratozoospermia,Oligozoospermia,Cryptospermias,Cryptozoospermias,Hypospermatogeneses,Low Sperm Counts,Oligoasthenoteratozoospermias,Sperm Count, Low,Sperm Counts, Low
D002872 Chromosome Deletion Actual loss of portion of a chromosome. Monosomy, Partial,Partial Monosomy,Deletion, Chromosome,Deletions, Chromosome,Monosomies, Partial,Partial Monosomies
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012729 Sex Chromosome Aberrations Abnormal number or structure of the SEX CHROMOSOMES. Some sex chromosome aberrations are associated with SEX CHROMOSOME DISORDERS and SEX CHROMOSOME DISORDERS OF SEX DEVELOPMENT. Sex Chromosome Abnormalities,Abnormalities, Sex Chromosome,Chromosome Abnormalities, Sex,Aberration, Sex Chromosome,Aberrations, Sex Chromosome,Abnormality, Sex Chromosome,Chromosome Aberration, Sex,Chromosome Aberrations, Sex,Chromosome Abnormality, Sex,Sex Chromosome Aberration,Sex Chromosome Abnormality
D014416 Tunisia A country in northern Africa between ALGERIA and LIBYA. Its capital is Tunis.

Related Publications

Wajih Hammami, and Olfa Kilani, and Mariem Ben Khelifa, and Wiem Ayed, and Sonia Abdelhak, and Abderrezzak Bouzouita, and Fethi Zhioua, and Ahlem Amouri
October 2019, Annales de biologie clinique,
Wajih Hammami, and Olfa Kilani, and Mariem Ben Khelifa, and Wiem Ayed, and Sonia Abdelhak, and Abderrezzak Bouzouita, and Fethi Zhioua, and Ahlem Amouri
January 2006, Archives of andrology,
Wajih Hammami, and Olfa Kilani, and Mariem Ben Khelifa, and Wiem Ayed, and Sonia Abdelhak, and Abderrezzak Bouzouita, and Fethi Zhioua, and Ahlem Amouri
May 2008, Pathologie-biologie,
Wajih Hammami, and Olfa Kilani, and Mariem Ben Khelifa, and Wiem Ayed, and Sonia Abdelhak, and Abderrezzak Bouzouita, and Fethi Zhioua, and Ahlem Amouri
June 2022, Clinical and experimental reproductive medicine,
Wajih Hammami, and Olfa Kilani, and Mariem Ben Khelifa, and Wiem Ayed, and Sonia Abdelhak, and Abderrezzak Bouzouita, and Fethi Zhioua, and Ahlem Amouri
August 2013, Iranian journal of reproductive medicine,
Wajih Hammami, and Olfa Kilani, and Mariem Ben Khelifa, and Wiem Ayed, and Sonia Abdelhak, and Abderrezzak Bouzouita, and Fethi Zhioua, and Ahlem Amouri
February 1997, The New England journal of medicine,
Wajih Hammami, and Olfa Kilani, and Mariem Ben Khelifa, and Wiem Ayed, and Sonia Abdelhak, and Abderrezzak Bouzouita, and Fethi Zhioua, and Ahlem Amouri
March 2000, Molecular and cellular endocrinology,
Wajih Hammami, and Olfa Kilani, and Mariem Ben Khelifa, and Wiem Ayed, and Sonia Abdelhak, and Abderrezzak Bouzouita, and Fethi Zhioua, and Ahlem Amouri
June 2003, Fertility and sterility,
Wajih Hammami, and Olfa Kilani, and Mariem Ben Khelifa, and Wiem Ayed, and Sonia Abdelhak, and Abderrezzak Bouzouita, and Fethi Zhioua, and Ahlem Amouri
September 2013, Turkish journal of urology,
Wajih Hammami, and Olfa Kilani, and Mariem Ben Khelifa, and Wiem Ayed, and Sonia Abdelhak, and Abderrezzak Bouzouita, and Fethi Zhioua, and Ahlem Amouri
January 2007, Genetic counseling (Geneva, Switzerland),
Copied contents to your clipboard!